Get started
Author

Büşra Özcan

Lipodystrophy Severity Score to Assess Disease Burden in Lipodystrophy
2025 · Rebecca J Brown, Baris Akinci, et al. · The Journal of Clinical Endocrinology & Metabolism · 9
Female form of persistent Müllerian duct syndrome
2020 · Nevra Zehra Elmas, Habib Ahmad Esmat, et al. · International Journal of Surgery Case Reports · 4
PDF
A novel pathogenic variant of the glucocorticoid receptor gene, causing generalized glucocorticoid resistance: a case report and review of the literature
2025 · Özge Güngör, Sena Yeral, et al. · HORMONES · 2
Finerenone Use in Heart Failure Patients with Type 2 Diabetes and Kidney Disease: An Analysis of the FINE-TURK Registry
2026 · Serap Yadigar, Suat Akgür, et al. · Cardiovascular Drugs and Therapy · 1
PDF
Real-World Comparison of Short-Term Adverse Events, Treatment Persistence, and Efficacy of Semaglutide and Tirzepatide: A Nationwide Multicenter Study
2026 · Sema Hepşen, Cem Haymana, et al. · Obesity Facts · 1
PDF
Real-World Effects of Finerenone in Diabetics Kidney Disease: Data From Fine-Turk Study
2026 · Serap Yadigar, Suat Akgür, et al. · Research Square · 1
PDF
The association of plasma pancreastatin levels with insulin resistance in patients with gestational diabetes mellitus
2023 · Gokcen Unal Kocabas, Ilgin Yildirim Simsir, et al. · Obstetric Medicine · 1
PDF
Early laboratory trajectories and short-term tolerability after finerenone initiationin diabetic kidney disease: the multicenter FINE-TURK study
2026 · Serap Yadigar, Suat Akgür, et al. · BMC Nephrology
Hyperkalemia risk with finerenone in diabetic kidney disease: a real-world analysis from the FINE-TURK cohort
2026 · Murat Özdede, Serap Yadigar, et al. · Clinical Kidney Journal
Works count: 9
Citation count: 19
H-index: 2
I10-index:
Year
Topic
Type